The Obesity-Cancer Link: What You Need to Know to Counsel Your Patients - Canadian Council On Continuing Education In Pharmacy (CCCEP)
Obesity rates have increased dramatically over the last three decades in Canada and globally, and continue to rise, with one in 5 Canadian adults characterized with obesity and 30-40% with overweight. Although the association between obesity and cancer has long been established, it is still a widely unrecognized contributor to cancer risk and cancer-related morbidity and mortality. Researchers estimate that obesity will soon surpass tobacco as the leading preventable cause of cancer, and historical data suggest that 15-20% of cancer deaths are attributed to overweight and obesity.Despite the growing burden of obesity, many clinicians are still hesitant to intervene. A lack of training in broaching the topic and in providing appropriate guidance for weight management in patients, especially those with a cancer diagnosis, often hinders health care professionals from addressing the issue with their patients.
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 1 CEU. This program has been reviewed and developed in collaboration by Obesity Canada.
Sarah Salama, BSc. Pharm., R. Ph, PharmD
Michael Boivin, B. Pharm., CDE, CTE, CTH
Carlene Oleksyn, BSc Pharm, CTH, CDE
Après avoir complété de programme de formation continue, le clinicien sera mieux en mesure de :
- Discuter de l’impact de la grippe parmi la population des adultes plus âgés;
- Passer en revue les options vaccinales destinées aux adultes plus âgés;
- Identifier les étapes nécessaires à l’amélioration des taux d’adoption vaccinale par les adultes plus âgés;
- Appliquer une approche structurée visant à recommander le vaccin antigrippal et à immuniser les personnes plus âgées;
- Prendre en charge les obstacles les plus courants en lien avec le refus ou la réticence face à la vaccination antigrippale.